The MCQs Course for Family Medicine Board Mastery.
3,060+ clinical vignette MCQs covering every domain of Family Medicine — each with deep explanations, 5-step reasoning pathways, comparison tables, and evidence-based references. No paywall. No trial. Always free.
Built specifically for the
family medicine clinician.
Family Medicine Residents
Preparing for ABFM boards? Medaptly's 3,060+ questions mirror the clinical vignette format and difficulty of the real exam — spanning all 16 FM domains you will be tested on. All free.
Primary audiencePracticing Family Physicians
Preparing for ABFM Continuous Certification or staying clinically sharp? Medaptly's domain-organized questions let you target gaps while maintaining breadth across your full scope of practice.
Great fitNP and PA Students
Covering primary care rotations or preparing for PANCE/PANRE? The depth of Medaptly's explanations — with clinical reasoning pathways, evidence-based references, and practice pearls — sharpens any primary care clinician.
CME ready16 Clinical Specialties.
Complete Coverage.
Every domain of the ABFM exam blueprint. Every question is tagged, organized, and drillable by topic — so you can target exactly where you need work.
Stop studying the old way.
Click each row to see how Medaptly transforms how you study.
You don't need a $300 question bank. You need better questions with better explanations — and access to them shouldn't depend on a paywall. That's exactly what 3,060+ free Medaptly MCQs deliver.
Enroll FreeNot just an answer.
A complete lesson.
Every single MCQ includes five structured sections designed to build the kind of clinical understanding that holds under exam pressure.
Rationale for Correct Answer
Detailed explanation covering pathophysiology, mechanisms, pharmacology, and clinical significance — not just a sentence.
Wrong Answer Analysis
Each distractor is dissected in a structured table — what misconception it targets, why it is wrong, and what it would be the answer to instead.
Clinical Reasoning Pathway
Numbered step-by-step walkthrough from the case stem to the correct answer — training exam-day logic, not rote memory.
High-Yield Clinical Pearl
A condensed, memorable clinical fact tied to each question — the kind of connection that turns a borderline score into a passing one.
Exam Strategy Notes
What the examiner is really testing, common traps to avoid, and how to approach similar questions — learn to think like the question writer.
Referenced Sources
Every explanation cites current guidelines — USPSTF, ADA, AHA/ACC, ACOG — and peer-reviewed literature. No guesswork.
3,060+ Questions.
Every FM Domain. Free.
Organized by specialty so you can study strategically — target gaps, drill systems, or simulate full board exams.
This is what every Medaptly question looks like.
Select an answer below, then explore all 6 explanation sections — the same depth you get on every single question in the free course.
Rationale
Full pathophysiology and mechanism, not just the answer.
Wrong Answer Analysis
Every distractor dissected — what it is, why it's wrong.
Reasoning Pathway
5-step walkthrough from stem to correct answer.
Pearl & Strategy
High-yield pearl and examiner thinking notes.
References
USPSTF, ADA, AHA/ACC, and peer-reviewed citations.
| Option | Why It Is Incorrect |
|---|---|
| A — Aspirin 81 mg | Not guideline-recommended for AF stroke preventionAF-related stroke is cardioembolic, not atherothrombotic. Aspirin has minimal efficacy against left atrial thrombus. AHA/ACC guidelines explicitly recommend against using antiplatelet therapy as a substitute for anticoagulation in AF. The AVERROES trial confirmed apixaban's superiority to aspirin with comparable bleeding. Aspirin alone = wrong answer for AF anticoagulation. |
| B — No anticoagulation | CHA₂DS₂-VASc of 3 clearly exceeds the treatment thresholdThe threshold is CHA₂DS₂-VASc ≥ 2 in males. This patient scores 3, corresponding to ~3.7% annual stroke risk. The NNT to prevent one stroke with anticoagulation is well below the NNH for major bleeding — benefit-risk ratio strongly favours anticoagulation. Age alone does not contraindicate treatment. |
| D — Warfarin | DOACs are preferred over warfarin in non-valvular AFCurrent guidelines recommend DOACs over warfarin for non-valvular AF unless specific contraindications exist (mechanical heart valves, moderate-severe mitral stenosis). This patient has non-valvular AF. His eGFR of 64 does not mandate warfarin. DOACs have lower intracranial haemorrhage rates, no INR monitoring burden, and fewer drug-food interactions. |
| E — Rivaroxaban | Valid DOAC, but apixaban has a more favourable bleeding profileRivaroxaban is an acceptable DOAC, but real-world data and network meta-analyses consistently show apixaban has lower major bleeding rates. Rivaroxaban also requires administration with a substantial evening meal for full absorption — a practical disadvantage. The distractor's claim of "superior efficacy in diabetes" is unsupported — both agents have comparable stroke-prevention efficacy. |
| Agent | Mechanism | AF Dosing | Key Advantage | Key Caution |
|---|---|---|---|---|
| Apixaban (Eliquis) preferred here | Direct Factor Xa inhibitor | 5 mg BID (or 2.5 mg BID if ≥2 of: age ≥80, wt ≤60 kg, Cr ≥1.5) | Lowest major bleeding in ARISTOTLE; no food requirement; lowest renal clearance (27%) | BID dosing; avoid strong CYP3A4 inhibitors (e.g. azole antifungals) |
| Rivaroxaban (Xarelto) | Direct Factor Xa inhibitor | 20 mg once daily with evening meal (15 mg if eGFR 15–50) | Once-daily dosing; well-studied in ROCKET-AF | Requires meal for absorption; higher GI bleeding vs apixaban; eGFR-dependent dosing |
| Dabigatran (Pradaxa) | Direct thrombin inhibitor | 150 mg BID (75 mg BID if eGFR 15–30) | Specific reversal agent (idarucizumab); superior stroke prevention at 150 mg vs warfarin | Highest GI bleeding among DOACs; GI intolerance common; 80% renal clearance — reduce in CKD |
| Warfarin (Coumadin) | Vitamin K antagonist (Factors II, VII, IX, X) | Individualised; target INR 2–3 | Preferred in valvular AF (mechanical valves, rheumatic MS); multiple reversal options | Narrow therapeutic window; frequent INR monitoring; drug-food interactions; higher intracranial bleed risk vs DOACs |
| Aspirin ± Clopidogrel | COX-1 / P2Y12 inhibition | Not guideline-recommended for AF | Role in concurrent ACS/PCI (triple therapy, limited duration) | Not appropriate as AF anticoagulation substitute; no cardioembolic stroke prevention benefit |
Memorise CHA₂DS₂-VASc as a reflex: CHF (1), HTN (1), Age ≥75 (2), DM (1), Stroke/TIA (2), Vascular disease (1), Age 65–74 (1), Sex female (1). Anticoagulate males with score ≥ 2, females with score ≥ 3. The most commonly tested scenario involves a patient just crossing the threshold — the ABFM loves borderline cases to test the cutoff.
For DOAC selection: Apixaban when bleeding risk matters (elderly, low weight, CKD) — lowest renal clearance (27%) makes it the safest choice in advancing CKD. At eGFR < 30, avoid rivaroxaban and dabigatran; apixaban can be used down to eGFR 15. Dose-reduce apixaban to 2.5 mg BID only when the patient meets ≥ 2 of the three criteria — not just one.
- 1January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. Journal of the American College of Cardiology. 2019;74(1):104–132. doi:10.1016/j.jacc.2019.01.011
- 2Granger CB, Alexander JH, McMurray JJV, et al. Apixaban versus Warfarin in Patients with Atrial Fibrillation (ARISTOTLE). New England Journal of Medicine. 2011;365(11):981–992. doi:10.1056/NEJMoa1107039
- 3Connolly SJ, Eikelboom J, Joyner C, et al. Apixaban in Patients with Atrial Fibrillation (AVERROES). New England Journal of Medicine. 2011;364(9):806–817. doi:10.1056/NEJMoa1007432
- 4Lip GYH, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the CHA₂DS₂-VASc score. Chest. 2010;137(2):263–272. doi:10.1378/chest.09-1584
Not another shallow — or expensive — question bank.
Most paid MCQ banks give you an answer and move on. Medaptly teaches you why, every time — and doesn't charge you for it.
| Feature | Typical Paid Q-Bank | Medaptly |
|---|---|---|
| Cost | $200–$500 | $0 — Always free |
| Clinical vignette format | Some | |
| Wrong answer analysis for every distractor | ||
| 5-step clinical reasoning pathway | ||
| High-yield clinical pearls | Rarely | |
| Drug class comparison tables | ||
| Exam strategy and examiner thinking notes | ||
| Peer-reviewed and guideline-cited sources | Sometimes | |
| 3,060+ family medicine-specific questions |
Learn why you got it wrong —
not just what's right.
Deep Understanding, Not Memorisation
Each explanation teaches the clinical reasoning behind the answer. You don't just remember C — you understand why it's C and why A, B, D, E aren't.
Think Like an Examiner
Exam strategy notes reveal what the question writer is testing. Once you see the patterns, similar questions become predictable.
Domain-by-Domain Mastery
Organised by FM specialty so you can target weak areas, do focused revision, or work through all 16 domains systematically.
Pearls That Stay With You
High-yield clinical pearls with every question create durable connections — the kind that surface under exam pressure when you need them most.
Study Anywhere, Anytime
Desktop, tablet, or phone. Ten questions during a lunch break, fifty after a shift, or a full domain session on a weekend. Always with you.
Evidence-Based and Free
Every explanation cites current guidelines — USPSTF, ADA, AHA/ACC, ACOG — and peer-reviewed literature. World-class quality, zero cost.
From day one to board day —
a clear path forward.
One free enrollment. All 3,060+ questions. All 16 clinical specialties. Web and mobile. The moment you sign up — no setup, no waiting, no payment.
Attack weak spots by drilling a single specialty, or simulate exam pressure with timed mixed-topic sets. Track your performance over time.
Right or wrong — you get the full 5-section explanation. Mechanism, clinical reasoning, comparison tables, pearls, and references. You never just move on.
With the clinical depth Medaptly builds, you are not memorising facts — you are thinking like a family physician. That is what holds up under pressure, and lasts beyond the boards.
Failing the boards isn't free.
This course is.
Other banks charge $200–$500 for less depth than Medaptly delivers. We charge nothing — and our questions go deeper.
The Cost of Failing
Board exam retake fees
Registration, scheduling, and exam fees for a second attempt.
Additional months of prep
Lost time, delayed credentialing, restricted practice scope.
Programme implications
Reporting requirements, remediation plans, reputation impact.
Free forever · No paywall · No catch.
Yes. The full course — all 3,060+ questions, every explanation section, web and mobile access — is free forever. No credit card, no trial period, no premium upgrade tier. Medaptly is committed to keeping high-quality medical education free for physicians worldwide.
Every question includes 5 detailed sections: correct answer rationale, wrong answer analysis (each distractor explained), a clinical reasoning pathway, a high-yield pearl, and exam strategy notes. Most banks give you a paragraph. Medaptly gives you a complete lesson per question.
All questions are organised across 16 clinical specialties aligned to the ABFM exam blueprint — Cardiovascular, Diabetes, Women's Health, Preventive Care, Mental Health, Musculoskeletal, and 10 more. You can drill a single specialty, target weak areas, or run timed mixed-topic sets.
Yes. Every question is a clinical vignette testing clinical reasoning — the same format used in ABFM boards. These are not simple recall questions. They test the depth of understanding that examiners expect from board-certified family physicians.
Yes. The course includes full web browser access plus native iOS and Android apps. Many users do 10–20 questions during breaks on their phone, then longer sessions on desktop. Progress syncs across all devices.
Medaptly's mission is to make high-quality medical education accessible to physicians worldwide regardless of geography or budget. We believe board prep shouldn't be a paywall — especially for residents and IMGs. Our model is funded to support free access in perpetuity.
Stop memorising.
Start understanding. Free.
3,060+ questions. 16 clinical specialties. Explanations that actually teach. Always free. Enroll and start studying in under 60 seconds.